These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35109835)

  • 1. Estimation the medical cost of multiple sclerosis in Iran; 2019-2020.
    Asadollahi M; Darvishi A; Azimi A; Annabi M; Jafariazar Z; Heshmat R
    BMC Health Serv Res; 2022 Feb; 22(1):137. PubMed ID: 35109835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic Burden of Multiple Sclerosis Drugs in Iran during 2011-2019.
    Asadollahi M; Darvishi A; Azimi A; Annabi M; Jafariazar Z; Heshmat R
    Iran J Public Health; 2023 Feb; 52(2):407-419. PubMed ID: 37089141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimated prevalence and incidence of multiple sclerosis in Iran.
    Etemadifar M; Izadi S; Nikseresht A; Sharifian M; Sahraian MA; Nasr Z
    Eur Neurol; 2014; 72(5-6):370-4. PubMed ID: 25341473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic burden of major depressive disorder: a case study in Southern Iran.
    Keshavarz K; Hedayati A; Rezaei M; Goudarzi Z; Moghimi E; Rezaee M; Lotfi F
    BMC Psychiatry; 2022 Aug; 22(1):577. PubMed ID: 36042423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does the multiple sclerosis (MS) map need to change again? An update of MS prevalence in Mazandaran province of Iran in 2018.
    Baghbanian SM; Cheraghmakani H; HabibiSaravi R; Azar A; Ghasemihamedani F
    BMC Neurol; 2020 Feb; 20(1):52. PubMed ID: 32050931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic costs incurred by the patients with multiple sclerosis at different levels of the disease: a cross-sectional study in Northwest Iran.
    Imani A; Gharibi F; Khezri A; Joudyian N; Dalal K
    BMC Neurol; 2020 May; 20(1):205. PubMed ID: 32446303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic burden of cardiovascular diseases before and after Iran's health transformation plan: evidence from a referral hospital of Iran.
    Alipour V; Zandian H; Yazdi-Feyzabadi V; Avesta L; Moghadam TZ
    Cost Eff Resour Alloc; 2021 Jan; 19(1):1. PubMed ID: 33390167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The catastrophic out-of-pocket health expenditure of multiple sclerosis patients in Iran.
    Gharibi F; Imani A; Dalal K
    BMC Health Serv Res; 2021 Mar; 21(1):257. PubMed ID: 33743679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic Burden of Gastric Cancer: A Case of Iran.
    Eghdami A; Ostovar R; Jafari A; Palmer AJ; Bordbar N; Ravangard R
    Cancer Control; 2019; 26(1):1073274819837185. PubMed ID: 30924358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The trend of incidence, prevalence, and DALY of multiple sclerosis in the Middle East and Northern Africa region compared to global, West Europe and, Iran's corresponding values during 1990-2017: Retrieved from global burden of diseases data.
    Abbastabar H; Bitarafan S; Mohammadpour Z; Mohammadianinejad SE; Harirchian MH
    Mult Scler Relat Disord; 2021 Jul; 52():102949. PubMed ID: 33894481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic burden of medication-overuse headache in Iran: direct and indirect costs.
    Togha M; Nadjafi-Semnani F; Martami F; Mohammadshirazi Z; Vahidpour N; Akbari-Sari A; Daroudi R
    Neurol Sci; 2021 May; 42(5):1869-1877. PubMed ID: 32948933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and incidence of multiple sclerosis in Ardabil, Northwest of Iran.
    Molazadeh N; Mohebi F; Altafi D; Sahraian MA
    Mult Scler Relat Disord; 2021 Jan; 47():102605. PubMed ID: 33217696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating the Economic Burden of Lung Cancer in Iran.
    Rezaei S; Akbari Sari A; Woldemichael A; Soofi M; Kazemi A; Karami Matin B
    Asian Pac J Cancer Prev; 2016 Oct; 17(10):4729-4733. PubMed ID: 27893204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Burden of multiple sclerosis in Iran from 1990 to 2017.
    Fattahi N; Saeedi Moghaddam S; Mohebi F; Rezaei N; Masinaei M; Fateh SM; Soleymani Hassanlouei E; Manoochehri F; Fattahi E; Sahraian MA; Moradi-Lakeh M; Mokdad AH; Naghavi M; Farzadfar F
    BMC Neurol; 2021 Oct; 21(1):400. PubMed ID: 34654397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of Multiple sclerosis and its clinical and demographic characteristics in Kurdish populations in western Iran (2020).
    Razazian N; Eskandarieh S; Siabani S; Afshari D; Sahraian MA; Khezri O; Rezaei M; Fakhri N
    Mult Scler Relat Disord; 2022 Jan; 57():103441. PubMed ID: 34896874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple sclerosis projection in Tehran, Iran using Bayesian structural time series.
    Amini P; Almasi-Hashiani A; Sahraian MA; Najafi M; Eskandarieh S
    BMC Neurol; 2021 Jun; 21(1):235. PubMed ID: 34167483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence of an increased prevalence of multiple sclerosis: a population-based study of Tehran registry during 1999-2018.
    Almasi-Hashiani A; Sahraian MA; Eskandarieh S
    BMC Neurol; 2020 May; 20(1):169. PubMed ID: 32359352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence, dimensions, and predictor factors of sexual dysfunction in women of Iran Multiple Sclerosis Society: a cross-sectional study.
    Ghasemi V; Simbar M; Ozgoli G; Nabavi SM; Alavi Majd H
    Neurol Sci; 2020 May; 41(5):1105-1113. PubMed ID: 31897948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct and indirect medical costs of bladder cancer in Iran.
    Raadabadi M; Daroudi R; Zendehdel K; Haghdoost AA; Ebadzadeh MR; Rashidian H
    Cost Eff Resour Alloc; 2023 Jan; 21(1):5. PubMed ID: 36647054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pain due to multiple sclerosis: analysis of the prevalence and economic burden in Canada.
    Piwko C; Desjardins OB; Bereza BG; Machado M; Jaszewski B; Freedman MS; Einarson TR; Iskedjian M
    Pain Res Manag; 2007; 12(4):259-65. PubMed ID: 18080044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.